Nasopharyngeal Carcinoma in A 51-Year-Old Male Patient

Authors

  • Faiq Razaan Student
  • Fivien Fedriani Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v17i1.1942

Keywords:

Case report, nasopharyngeal carcinoma, orbital infiltration

Abstract

Nasopharyngeal carcinoma is a malignant epithelial tumor arising from the nasopharynx and remains one of the most common head and neck cancers in Indonesia. Its etiology is multifactorial, involving Epstein-Barr virus infection, genetic susceptibility, and environmental exposures such as smoking and consumption of preserved foods. Because early symptoms are often nonspecific, many patients present at an advanced stage. This case report describes the clinical manifestations, risk factors, and diagnostic approach in a 51-year-old man with nasopharyngeal carcinoma and orbital infiltration. The patient presented with a progressively enlarging neck mass for nine months accompanied by hearing loss, tinnitus, epistaxis, diplopia, right-sided facial numbness, nausea, and fatigue. Physical examination revealed cervical lymphadenopathy, right ptosis, anisocoria, multiple cranial nerve deficits, and unilateral hearing impairment. Head computed tomography demonstrated a mass extending to adjacent structures with compression of the optic nerve, while histopathological examination of the nasopharyngeal biopsy revealed keratinizing squamous cell carcinoma, confirming the diagnosis of nasopharyngeal carcinoma with orbital infiltration. The patient had a long history of heavy smoking and frequent consumption of salted fish, both recognized risk factors for this malignancy. Initial management consisted of symptomatic and supportive treatment, followed by referral to a tertiary oncology center for definitive chemoradiotherapy. This case highlights the importance of early recognition of persistent cervical lymphadenopathy and cranial nerve involvement to facilitate timely diagnosis, appropriate staging, and improved clinical outcomes in patients with nasopharyngeal carcinoma.

References

World Health Organization. 10 facts about cancer [internet]; 2017.

Ridwan W, Kharisma Y, Indrina JA. Tinjauan Pustaka Histopatologi Karsinoma Nasofaring di RS Al-Ihsan Bandung Periode 2020-2024. InBandung Conference Series: Medical Science 2026 Jan 30 (Vol. 6, No. 1, pp. 1115-1124).

Ferlay J, Soerjomataram I, Dikshit R, Esher S, Mather C, Forman D, Dkk. Cancer insidence and mortality worldwide: sources, methods, and major patterns in globocan [internet]. United Kingdom: Felay J and associated; 2012.

Kementrian Kesehatan RI. Situasi penyakit kanker. Jakarta: Kemenkes RI; 2015.

Harahap AM, Priawan I. Hubungan Karsinoma Nasofaring dengan EipstennBarr Virus (EBV) Terhadap stadium Klinis Pasien Penderita Kanker Nasofaring. Jurnal Medika Sehat. 2023 Jan 28;1(1):35-42.

Yenita AA. Penelitian Korelasi antara Latent Membrane Protein-1 Virus Epstein-Barr dengan P53 pada Karsinoma Nasofaring (Penelitian Lanjutan). Jurnal Kesehatan Andalas. 2012. 1(1): 4–6.

Rahman S, Budiman BJ, Subroto H. Faktor Risiko Non Viral Pada Karsinoma Nasofaring. Jurnal Kesehatan Andalas. 2015; 4(3): 988-995.

Zheng, at all. Nasopharingeal carcinoma incidence and mortality in china. Chin J Cancer. 2017. 1(1): 1-8.

Soepardi EA, Iskandar N, Bashiruddin J, Rastuti RD. Buku ajar ilmu kesehatan telinga hidung tenggorok kepala leher. Jakarta: fakultas kedokteran universitas Indonesia. 2008.

Lee N, Riaz N, Ove R, Reyngold Ml, Foote RL, Bonner JA, Nasopharyngeal carcinoma. Dalam : Gunderson LL, Tepper JE. Clinical radiation oncology. 4th ed. Usa : Elsevier; 2016.

Kadhoka ZT. Nasopharyngeal carcinoma: past, present, and future directions. Sweden: Departement of oncology institute of clinical science. 2010.

Guo X, Jhonson RC, Deng H, Liao J, Guan L, Nelson GW, dkk. Evaluation of nonviral risk factor for nasopharyngeal carcinoma in a high risk population of Shoutern China. Int J Cancer. 2009; 124: 2942-7.

Adham M, Kurniawan AN, Muhtadi A, Roezin A, Hermani B, Gondhowiardjo S, Dkk. Nasopharingeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012. 31(4): 186-196.

Amstrong R, Imrey P, Sann M, Amstrong J, Yu M, Sani S. Nashopharingeal carcinoma in Malaysian chinese: salted fish and other dietary exposures. Int J Cancer. 1998. 77 (1): 228-235.

Widiono K, Yusmawan W, Naftali Z. Perbandingan five year survival rate penderita karsinoma nasofaring pada modalitas kemoterapi dan kemoradiasi. Jurnal Kedokteran Diponegoro. 2017. 2(9): 705-715.

National Comprehensive Cancer Network (NCCN), 2026.

Suryakusuma L, Dewati E, Sekarutami SM, Prihartono J, Aninditha T. Perbaikan paresis saraf kranial III, IV, V, dan VI berdasarkan pemeriksaan neurologi klinis pada karsinoma nasofaring pascaterapi. Neurona. 2016. 33(4): 258

Published

2026-07-10

How to Cite

Razaan, F., & Fedriani, F. (2026). Nasopharyngeal Carcinoma in A 51-Year-Old Male Patient. Medical Profession Journal of Lampung, 17(1), 210-216. https://doi.org/10.53089/medula.v17i1.1942

Issue

Section

Artikel